Low antileishmanial drug exposure in HIV-positive visceral leishmaniasis patients on antiretrovirals: an Ethiopian cohort study

BACKGROUND: Despite high HIV co-infection prevalence in Ethiopian visceral leishmaniasis (VL) patients, the adequacy of antileishmanial drug exposure in this population and effect of HIV-VL co-morbidity on pharmacokinetics of antileishmanial and antiretroviral (ARV) drugs is still unknown. METHODS:...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Antimicrob Chemother
Autors principals: Kip, Anke E, Blesson, Séverine, Alves, Fabiana, Wasunna, Monique, Kimutai, Robert, Menza, Peninah, Mengesha, Bewketu, Beijnen, Jos H, Hailu, Asrat, Diro, Ermias, Dorlo, Thomas P C
Format: Artigo
Idioma:Inglês
Publicat: Oxford University Press 2021
Matèries:
Original Research
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC8050768/
https://ncbi.nlm.nih.gov/pubmed/33677546
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jac/dkab013
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars